Precision Medicine: A Collaborative and Multidisciplinary Approach to Identifying Biomarkers

Expert perspectives on molecular testing and best practices for identifying patients who may be eligible for treatment with newly approved targeted therapies.

EP. 1: Targetable Mutations and Rearrangements in Lung Cancers

February 7th 2023

Expert participants share their perspective on the advent of precision medicine in lung cancer, following the discovery of several key driver mutations and alterations.

EP. 2: Targetable Mutations Found in Breast Cancers

February 7th 2023

Shared insight on key driver mutations and corresponding precision medicine in the setting of breast cancer management.

EP. 3: Addressing Barriers to Adequate Biomarker Testing in Cancer Care

February 13th 2023

Key opinion leaders highlight challenges to adequate biomarker testing in cancer care and consider the value of collaboration to overcome these barriers.

EP. 4: Optimizing Cancer Care: Interpreting and Communicating Biomarker Testing Results

February 13th 2023

Comprehensive discussion on how best to interpret and document results from biomarker testing, along with considerations for communicating results with other healthcare professionals.

EP. 5: Armamentarium of Biomarker Testing Strategies in Cancer Care

February 20th 2023

Expert perspectives on the wide array of biomarker testing modalities available to patients receiving treatment for cancer.

EP. 6: Updating Biomarker Testing Strategies as Cancer Care Evolves

February 20th 2023

Timothy J. Pluard, MD; Ossama Tawfik, MD; and Sujith R. Kalmadi, MD, reflect on how they update their biomarker testing strategies as the field of cancer care and precision medicine evolves.

EP. 7: Optimizing the Timing and Utilization of Biomarker Testing in Cancer Care

February 27th 2023

Expert pathologist Samuel K. Caughron, MD, FCAP, shares best strategies for the timing and utilization of biomarker testing while managing patients with cancer.

EP. 8: Improving Uptake of Biomarker Testing and Precision Medicine in Cancer Care

February 27th 2023

Key opinion leaders in the field of cancer management discuss resistance to the uptake of biomarker testing and precision medicine, with deference to the community setting.

EP. 9: The Value of Molecular Tumor Boards and Multidisciplinary Care

March 6th 2023

Comprehensive discussion on the role of tumor boards—or more specifically, molecular tumor boards—in the optimal management of patients with cancer.

EP. 10: Role of a Pharmacist in the Multidisciplinary Approach to Identifying Biomarkers

March 6th 2023

Expert perspectives on the role of an oncologic pharmacist within a tumor board and how they can improve upon precision medicine in cancer management.

EP. 11: Role of a Pharmacist in Developing Treatment Pathways and Educating Patients

March 13th 2023

Ryan Haumschild, PharmD, MS, MBA, reflects on how oncologic pharmacists can help to develop treatment pathways and educate patients on precision medicine.

EP. 12: Future Directions in Precision Medicine: An Evolving Treatment Landscape

March 13th 2023

Closing out their discussion on biomarkers and precision medicine in cancer care, key opinion leaders look toward future evolutions in the oncology landscape.